| Source HCPCS Code |
|
Target NDC Code |
J1562
|
⇄
|
00053-7596-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J1562
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG
|
⇄
|
00053-7596-03
VIVAGLOBIN (PF) 160 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
J1562
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG
|
⇄
|
00053-7596-10
VIVAGLOBIN (PF) 160 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
5/6/2013 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
J1562
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG
|
⇄
|
00053-7596-15
VIVAGLOBIN (PF) 160 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
J1562
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG
|
⇄
|
00053-7596-20
VIVAGLOBIN (PF) 160 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
6/8/2013 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
J1562
INJECTION, IMMUNE GLOBULIN (VIVAGLOBIN), 100 MG
|
⇄
|
00053-7596-25
VIVAGLOBIN (PF) 160 MG/ML
|
| Detail Information |
| Relationship Start Date |
1/1/2007 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
VL |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|